These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12430251)

  • 21. [The prevention, diagnosis and treatment of ischemic heart disease in servicemen].
    Rakov AL; Beliavskiĭ VI
    Voen Med Zh; 1998 Jan; 319(1):52-4. PubMed ID: 9505548
    [No Abstract]   [Full Text] [Related]  

  • 22. [Secondary prevention of myocardial ischemia. From theory to clinical reality: preliminary results of the EUROASPIRE study in Italy. European Action on Secondary Prevention through Intervention to Reduce Events].
    Ambrosio GB; Leprotti C; Vanuzzo D; Pilotto L; Pedrocco A; Perissinotto F; Stritoni P; Gallo A; Rossi L; Zardini P
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():139S-142S. PubMed ID: 9004814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of cardiovascular ischemic events: high-risk and secondary prevention.
    Genest J; Pedersen TR
    Circulation; 2003 Apr; 107(15):2059-65. PubMed ID: 12707251
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evidence Based Secondary Prevention of Ischemic Heart Disease. Topics: I. Advances and Evidence of Pharmacotherapy: 3. Antidiabetic Agents].
    Kamiya H; Nakamura J
    Nihon Naika Gakkai Zasshi; 2017 Feb; 106(2):216-25. PubMed ID: 30182646
    [No Abstract]   [Full Text] [Related]  

  • 25. [Small-dense low-density lipoproteins].
    Kanno T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():68-70. PubMed ID: 15658265
    [No Abstract]   [Full Text] [Related]  

  • 26. [Endothelial function and ischemic heart disease--approach from vascular endocrinology].
    Itoh H
    Nihon Rinsho; 2003 May; 61 Suppl 5():813-26. PubMed ID: 12809039
    [No Abstract]   [Full Text] [Related]  

  • 27. [Progress in the treatment of diabetic patients with ischemic cardiopathy].
    Gaxiola-López E; Eng-Ceceña L
    Arch Cardiol Mex; 2002; 72 Suppl 1():S69-75. PubMed ID: 12001874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impaired glucose tolerance in patients with ischemic heart diseases].
    Yasuda S; Miyazaki S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():300-2. PubMed ID: 15779392
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.
    Das SR; Drazner MH; Yancy CW; Stevenson LW; Gersh BJ; Dries DL
    Am Heart J; 2004 Nov; 148(5):883-8. PubMed ID: 15523322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes and percutaneous coronary intervention: the sweet smell of success?
    Quinn MJ; Moliterno DJ
    Am Heart J; 2003 Feb; 145(2):203-5. PubMed ID: 12595833
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tissue renin-angiotensin system and ischemic heart diseases].
    Suzuki J; Higaki J; Horiuchi M
    Nihon Rinsho; 2003 May; 61 Suppl 5():837-42. PubMed ID: 12809042
    [No Abstract]   [Full Text] [Related]  

  • 32. [Atherosclerosis and menopause].
    Alegría E; Velasco S; Bolao IG; Iglesias I
    Rev Med Univ Navarra; 1994; 39(2):57-60. PubMed ID: 7724962
    [No Abstract]   [Full Text] [Related]  

  • 33. [Heart disease and diabetes: from pathophysiology to therapeutic options].
    Fragasso G; Palloshi A; Bassanelli G; Steggerda R; Montano C; Margonato A
    Ital Heart J; 2004 Mar; 5 Suppl 2():4S-15S. PubMed ID: 15074772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Awareness of cardiovascular risk factors in ischaemic heart disease: implications during the projection of secondary prevention interventions.
    Montinaro S; Mazzetti S; Vasicuro C; Acquistapace F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1052-6. PubMed ID: 18799969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gender differences in ischemic heart disease].
    Jensen J
    Ugeskr Laeger; 2007 Jun; 169(25):2435-7. PubMed ID: 17594838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary and secondary prevention of ischemic cardiopathy. A meta-analysis with meta-regression as a biologic mechanism: reflections on clinical practice based on scientific evidence].
    Marchioli R; Marfisi RM
    G Ital Cardiol; 1998 Apr; 28(4):434-59. PubMed ID: 9616860
    [No Abstract]   [Full Text] [Related]  

  • 37. Silent myocardial ischaemia. To screen or not to screen? That is..
    Valensi P
    Arch Cardiovasc Dis; 2008 Sep; 101(9):509-11. PubMed ID: 19041833
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diabetes mellitus and ischemic heart disease].
    Dresslerová I; Vojácek J
    Vnitr Lek; 2010 Apr; 56(4):301-6. PubMed ID: 20465100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macronutrient advice for ischemic heart disease prevention.
    Jakobsen MU; Overvad K
    Curr Opin Lipidol; 2011 Feb; 22(1):33-6. PubMed ID: 20935565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between symptomatology of acute ischemic heart disease and glucose metabolism balance].
    Gaeta G; Massari A; Scala R; De Rosa V; Boccalatte M; Bolletti Censi M
    Minerva Cardioangiol; 1994; 42(7-8):333-8. PubMed ID: 7970026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.